Non-surgical treatment for gum disease using chitosan and enamel matrix
Official title: Non-surgical Treatment of Mandibular and Maxillary Molar Furcations With a Chitosan Brush With Adjunct Enamel Matrix Derivative- a Split-mouth Randomized Clinical Trial
Run by Riga Stradins University · NCT06684769 · Data updated 2026-11-12
This study is testing a new non-surgical treatment using a special brush and gel to help people with advanced gum disease and specific tooth issues.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Riga Stradins University Academic / other |
| Drugs / interventions | Chemotherapy |
| Locations | 1 site (Riga) |
| Status | Recruiting |
| Started | November 15, 2024 |
| Main results expected | August 2026 |
| Study ends | November 2026 |
| Registry record updated | September 8, 2025 |
| Trial ID | NCT06684769 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with stage III or IV periodontitis and specific furcation defects in their molars.
✕Probably not a fit
Patients with systemic diseases affecting periodontal health or those who have not completed prior periodontal treatments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of a chitosan brush combined with an enamel matrix derivative for the non-surgical treatment of furcation defects in patients with stage III or IV periodontitis. Participants will be randomly assigned to receive either the experimental treatment or a control intervention after receiving detailed oral hygiene instructions. The study will focus on patients with specific types of furcation defects in their molars, ensuring a targeted approach to treatment. The trial will be conducted at the Riga Stradiņš University Institute of Stomatology in Latvia.
Why it matters
Potential benefit: If successful, this treatment could improve periodontal health and reduce the need for surgical interventions in patients with advanced gum disease.
How similar studies have gone: While similar approaches have been explored, this specific combination of treatments is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: 1. The patient is 18 years of age or older 2. The patient does not have any systemic diseases that may affect the results of the study 3. The patient has a plaque index of 20% or less at the study entry 4. The patient has a history of severe localized or generalized periodontitis (stage III or IV) 5. Completed the first and second steps of periodontal treatment (According to Treatment of stage I-III periodontitis-The EFP S3 level clinical practice guideline) (Sanz M. et al.) 6. Buccal and/or lingual Class 2A and/or 2B furcation involvement (FI) defects on both sides of the Mandibular first and/or second molars after completing the first and second steps of periodontal treatment. 7. Buccal Class 2A and/or 2B furcation involvement (FI) defects on both sides of the maxillary first and/or second molars after completion of the first and second step of periodontal treatment if furcation involvement on the palatal side (mesiopalatal and distopalatal) does not exceed Class 1. 8. Psychological appropriateness 9. Consents to all follow-up visits Exclusion Criteria: 1. Patients who have systemic diseases that may affect the results of the study 2. Use of medications that may affect study results (anti-osteoporotic drugs, statins, corticosteroids, anticoagulants) 3. Patients who use calcium channel blockers, cyclosporine A or antiepileptic drugs if there are clinically visible hyperplastic changes in the gingival margin. 4. Patients who have received any type of systemic antibiotics in the last six months prior to the start of the study and patients starting antibiotics during the study 5. Patients requiring antibiotic premedication prior to periodontal treatment 6. Oncological disease 7. Chemotherapy and/or radiotherapy (active or history) 8. Pregnancy and breastfeeding 9. Any condition or current treatment which, in the opinion of the investigator and/or consulting physician, may present an unreasonable risk 10. Psychoemotional disorders and depression 11. Use of antipsychotic medication or antidepressants 12. Lack of patient motivation to undertake adequate dental care at home or complete periodontal treatment, patients residing outside Latvia 13. Molars with combined endodontic-periodontal lesions, active endodontic infection 14. Prosthetic factors for molars not allowing clinical measurements 15. Huge restoration or amalgam fillings that could potentially cause fractures or furcation involvement 16. Enamel pearls or filling or crown margins 17. Decay or root resorption 18. Tooth mobility degree 3 19. Molars in which the gingival margin is positioned apically from the entrance into the furcation area 20. Clinical attachment level and or pockets mesial and distal to the furcation involvement defect of 6 or more mm 21. Strong vomiting reflex that would prevent adequate periodontal treatment 22. People close to the study subjects, work colleagues, relatives, etc.
Where it's running
-
Riga Stradins University Institute of Stomatology
Riga, Latvia Recruiting
Study contacts
- Study coordinator: Anete Vaškevica, DDS
- Email: anete.vaskevica@rsu.lv
- Phone: +37120202028
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mandibular molar furcation defects in advanced periodontitis: a regenerative treatment comparison
In people with advanced gum disease, this study tests two regenerative treatments for Hamp Class II furcation defects in lower molars to see which works better and whether CBCT imaging matches what clinicians find during surgery.
-
A-PRF+ with Xenograft vs Collagen Membrane with Xenograft for Degree II Furcation Defects in Mandibular Molars
This trial tests whether using advanced platelet-rich fibrin with a xenograft works better than a collagen membrane with a xenograft to treat degree II furcation defects in lower first molars of adults with periodontitis.
-
HbA1c screening in dental care to guide primary care referral for adults with advanced periodontitis
This study tests whether a quick HbA1c test in dental clinics can find elevated blood sugar in adults with advanced periodontitis and help refer them to their primary care doctor.
-
Masticatory Performance in Adults with Periodontitis
This study tests whether chewing performance correlates with how severe periodontitis is in adults who have the condition.
-
Probiotics with or without vitamin B12 added to non-surgical treatment for advanced periodontitis
This study will see if taking a probiotic lozenge alone or together with vitamin B12 during non-surgical periodontal treatment changes the oral microbiome and helps adults with Stage III or IV periodontitis.
-
3-month liquid platelet-rich fibrin treatment used during deep cleaning for stage II–IV periodontitis
This 3-month test will see if flushing diseased gum pockets with your own liquid platelet-rich fibrin after deep cleaning helps healing for people with stage II–IV periodontitis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.